TriSalus Life Sciences Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, TriSalus Life Sciences Inc had 56.55M in cash and cash equivalents.

TriSalus Life Sciences Inc reported 69.19M in total liabilities as of the latest reported quarter, including 11.50M in current liabilities and 57.69M in non-current liabilities.

As of the latest reported quarter, TriSalus Life Sciences Inc's total assets were 35.33M, consisting of 32.24M in current assets and 3.09M in non-current assets.

TriSalus Life Sciences Inc reported -33.86M in total shareholders' equity as of the latest reported quarter.